824P Real-world-data (RWD) on platinum (Pt) outcomes after PARP inhibitors (PARPi) progression in high grade serous ovarian cancer (HGSOC) patients (p)

Autor: Plaja Salarich, A., Teruel García, I., Pardo Burdalo, B., Gil-Martin, M., Piulats, J.M., Fina Planas, C., Barretina Ginesta, M.P., Ferrando Diez, A., Notario Rincon, L., Pous Badia, A., Gonzalez Valencia, A., Esteve Gomez, A., Romeo Marin, M.
Zdroj: In Annals of Oncology September 2020 31 Supplement 4:S622-S622
Databáze: ScienceDirect